BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25651604)

  • 21. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
    Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: The HeartStrong Randomized Clinical Trial.
    Volpp KG; Troxel AB; Mehta SJ; Norton L; Zhu J; Lim R; Wang W; Marcus N; Terwiesch C; Caldarella K; Levin T; Relish M; Negin N; Smith-McLallen A; Snyder R; Spettell CM; Drachman B; Kolansky D; Asch DA
    JAMA Intern Med; 2017 Aug; 177(8):1093-1101. PubMed ID: 28654972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
    Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
    [No Abstract]   [Full Text] [Related]  

  • 26. Does medication adherence lower Medicare spending among beneficiaries with diabetes?
    Stuart B; Davidoff A; Lopert R; Shaffer T; Samantha Shoemaker J; Lloyd J
    Health Serv Res; 2011 Aug; 46(4):1180-99. PubMed ID: 21413981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
    Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
    J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
    Sun P; Lian J
    Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study.
    Dharmarajan K; Hsieh AF; Kulkarni VT; Lin Z; Ross JS; Horwitz LI; Kim N; Suter LG; Lin H; Normand SL; Krumholz HM
    BMJ; 2015 Feb; 350():h411. PubMed ID: 25656852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
    Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
    Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction β-Blocker Utilization, Adherence, and Rehospitalization.
    Bykov K; Gagne JJ; Wang B; Choudhry NK
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004096. PubMed ID: 30354573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.
    Colantonio LD; Deng L; Chen L; Farkouh ME; Monda KL; Harrison DJ; Maya JF; Kilgore ML; Muntner P; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):601-610. PubMed ID: 30446883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction Patients.
    Mehta SJ; Asch DA; Troxel AB; Lim R; Lewey J; Wang W; Zhu J; Norton L; Marcus N; Volpp KG
    Med Care; 2019 Feb; 57(2):e9-e14. PubMed ID: 30045159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
    J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.
    Wei L; Wang J; Thompson P; Wong S; Struthers AD; MacDonald TM
    Heart; 2002 Sep; 88(3):229-33. PubMed ID: 12181210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel application of approaches to predicting medication adherence using medical claims data.
    Zullig LL; Jazowski SA; Wang TY; Hellkamp A; Wojdyla D; Thomas L; Egbuonu-Davis L; Beal A; Bosworth HB
    Health Serv Res; 2019 Dec; 54(6):1255-1262. PubMed ID: 31429471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.